Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Entain reprices, extends dollar-denominated term loans

(Sharecast News) - Entain announced the successful repricing and extension of its dollar-denominated term loans on Thursday, in a move that it said would reduce annual interest costs by £10m while extending the maturity profile of its debt. The FTSE 100 gambling giant, which owns brands including Ladbrokes, Cora and BetMGM, said the refinancing was net debt neutral.

It said it reduced the margin on its $1.1bn Term Loan B, previously due in March 2027, by 35 basis points to 225 basis points over Term SOFR.

The maturity was extended to July 2032, and the loan was allocated at an original issue discount of 99.875.

Entain also repriced its larger $2.2bn Term Loan B due October 2029, cutting the margin by 50 basis points to 225 basis points over Term SOFR.

That facility was allocated at par and the maturity remained unchanged.

The company said the refinancing actions would enhance its capital structure by lowering funding costs and extending maturities, without increasing leverage.

At 1201 BST, shares in Entain were down 0.47% at 1,012.25p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.